Trial Profile
Prospective Study on the Efficacy and Safety of 2 Week or 3 Week Xelox Regimen for Adjuvant Chemotherapy in Colorectal Patients After Surgery
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 26 Aug 2021
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin
- Indications Carcinoma; Colorectal cancer
- Focus Therapeutic Use
- 24 Aug 2021 Status changed from recruiting to completed.
- 26 May 2021 Planned primary completion date changed from 30 Dec 2020 to 28 May 2021.
- 14 Jul 2019 Planned primary completion date changed from 31 Dec 2020 to 30 Dec 2020.